BERNSTEIN HAROLD (President, R&D & CMO) sold 15K shares of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $736.4K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/20/2026ACC: 0002050172-26-000017
Officer· President, R&D & CMO
Since Mar 2026
-15K
Net shares
Net seller
$736.4K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+15K
Price / share
$10.42
Trade value
$156.30K
% of position
New position
3/20/2026
0.00→15K
Common Stock
Direct
Shares
−6.16K
Price / share
$48.20
Trade value
$296.98K
% of position
41.1%
3/20/2026
15K→8.84K
Common Stock
Direct
Shares
−3.79K
Price / share
$49.32
Trade value
$187.17K
% of position
42.9%
3/20/2026
8.84K→5.04K
Common Stock
Direct
Shares
−5.04K
Price / share
$50.02
Trade value
$252.29K
% of position
New position
3/20/2026
5.04K→0.00
Total
Net shares
+0.00
Net value
-$580.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/20/2026 | M · Option Exercise | +15K | $10.42 | $156.30K | New position | 0.00 | 15K |
| Common Stock Direct | 3/20/2026 | S · Sale | −6.16K | $48.20 | $296.98K | 41.1% | 15K | 8.84K |
| Common Stock Direct | 3/20/2026 | S · Sale | −3.79K | $49.32 | $187.17K | 42.9% | 8.84K | 5.04K |
| Common Stock Direct | 3/20/2026 | S · Sale | −5.04K | $50.02 | $252.29K | New position | 5.04K | 0.00 |
| Total | +0.00 | -$580.14K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
10.42
Held after
252.41K
Exercisable
—
3/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15K shares | 3/20/2026 | M · Option Exercise | −15K | 10.42 | — | 252.41K |